Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 58.52B | 59.77B | 59.38B | 57.79B | 54.30B | 46.88B |
Gross Profit | 32.59B | 33.02B | 31.98B | 31.48B | 31.21B | 27.25B |
EBITDA | 17.14B | 20.25B | 18.97B | 18.91B | 17.39B | 11.22B |
Net Income | 7.12B | 5.86B | 5.34B | 5.97B | 4.67B | 1.41B |
Balance Sheet | ||||||
Total Assets | 211.11B | 206.64B | 219.34B | 212.94B | 217.63B | 226.41B |
Cash, Cash Equivalents and Short-Term Investments | 7.27B | 11.39B | 10.40B | 10.07B | 12.47B | 15.56B |
Total Debt | 75.58B | 72.17B | 78.17B | 79.99B | 88.83B | 98.56B |
Total Liabilities | 119.69B | 117.94B | 126.66B | 128.66B | 138.29B | 148.06B |
Stockholders Equity | 80.67B | 78.24B | 81.85B | 73.40B | 68.67B | 68.02B |
Cash Flow | ||||||
Free Cash Flow | 11.66B | 11.19B | 8.63B | 8.14B | 9.16B | 7.11B |
Operating Cash Flow | 15.20B | 15.05B | 13.27B | 13.30B | 14.80B | 10.89B |
Investing Cash Flow | -3.18B | -3.26B | -4.35B | -4.62B | -5.88B | 6.34B |
Financing Cash Flow | -12.08B | -9.85B | -8.60B | -10.62B | -11.60B | -8.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | 2.21B | 13.90 | 10.55% | 3.82% | 13.92% | 32.69% | |
75 Outperform | 36.87B | 13.85 | 15.95% | 1.96% | -0.79% | -10.83% | |
75 Outperform | $116.70B | 16.49 | 8.97% | 1.78% | -2.06% | 21.03% | |
72 Outperform | 20.01B | 35.59 | 8.99% | 4.59% | -2.73% | -37.93% | |
66 Neutral | 8.95B | 8.88 | 7.72% | 4.20% | -5.48% | -6.99% | |
60 Neutral | 23.53B | -55.19 | -6.09% | 3.08% | -0.47% | -117.62% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |